Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00702104
First received: June 19, 2008
Last updated: May 13, 2013
Last verified: May 2013
  Purpose

RATIONALE: Screening may help doctors find prostate cancer sooner, when it may be easier to treat.

PURPOSE: This research study is looking at whether patients who are being screened for prostate cancer have been previously screened.


Condition Intervention
Prostate Cancer
Other: survey administration

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: PSA Screening of African-American Men in The San Francisco Area

Resource links provided by NLM:


Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • Degree to which patients who are being screened for prostate cancer have been previously screened [ Designated as safety issue: No ]

Study Start Date: January 2003
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Detailed Description:

OBJECTIVES:

Primary

  • To determine the degree to which patients who are being screened for prostate cancer have been previously screened.

OUTLINE: Participants complete questions on a survey about prior prostate-specific antigen blood tests done for the purpose of screening for prostate cancer and are asked about their pastor, church, and how they heard about the SELECT study to determine the degree to which African-American men in a church-going population have been previously screened.

  Eligibility

Ages Eligible for Study:   35 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

community sample

Criteria

DISEASE CHARACTERISTICS:

  • Meets all of the following criteria:

    • African-American male
    • Age 35 years or older
    • Attends church on a regular basis
    • Resides in the San Francisco area

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00702104

Locations
United States, California
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States, 94115
Sponsors and Collaborators
University of California, San Francisco
Investigators
Principal Investigator: Mack Roach, MD University of California, San Francisco
  More Information

Additional Information:
No publications provided

Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00702104     History of Changes
Other Study ID Numbers: CDR0000596996, UCSF-0555105, UCSF-H7056-21713-06
Study First Received: June 19, 2008
Last Updated: May 13, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, San Francisco:
prostate cancer

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on September 14, 2014